Education
About Us
Working with TipRanks
Follow Us
Quest Pharmatech Inc (TSE:QPT)
:QPT
QPT Stock Chart & Stats
C$0.04
--
Market closed
C$0.04
--
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.06
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.04K
Market Cap
C$6.77M
Enterprise ValueC$8.52M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-3.71
Next Earnings
Jun 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding169,129,240
10 Day Avg. Volume15,776
30 Day Avg. Volume13,040
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Quest Pharmatech News
QPT FAQ
What was Quest Pharmatech Inc’s price range in the past 12 months?
Quest Pharmatech Inc lowest stock price was C$0.02 and its highest was C$0.06 in the past 12 months.
What is Quest Pharmatech Inc’s market cap?
Quest Pharmatech Inc’s market cap is C$6.77M.
When is Quest Pharmatech Inc’s upcoming earnings report date?
Quest Pharmatech Inc’s upcoming earnings report date is Jun 03, 2026 which is in 142 days.
How were Quest Pharmatech Inc’s earnings last quarter?
Quest Pharmatech Inc released its earnings results on Dec 17, 2025. The company reported C$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.006.
Is Quest Pharmatech Inc overvalued?
According to Wall Street analysts Quest Pharmatech Inc’s price is currently Overvalued.
Does Quest Pharmatech Inc pay dividends?
Quest Pharmatech Inc does not currently pay dividends.
What is Quest Pharmatech Inc’s EPS estimate?
Quest Pharmatech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quest Pharmatech Inc have?
Quest Pharmatech Inc has 169,129,240 shares outstanding.
What happened to Quest Pharmatech Inc’s price movement after its last earnings report?
Quest Pharmatech Inc reported an EPS of C$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Quest Pharmatech Inc?
Currently, no hedge funds are holding shares in TSE:QPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Quest Pharmatech Inc
Quest PharmaTech Inc is a Canadian based pharmaceutical company. The company through its subsidiary is developing antibody-based immunotherapeutic products for cancer. In addition, it owns the photodynamic therapy technology for oncology and dermatology applications.
Technical Analysis
Aptose Biosciences
―
XORTX Therapeutics Inc
―
Kane Biotech
―
BetterLife Pharma
―
BioVaxys Technology
―